Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Firm”), a medical know-how firm centered on creating micro-systems-based wearable diagnostic gadgets and at present commercializing sugarBEAT®, its non-invasive and versatile steady glucose monitor (“CGM”), along with BEAT™diabetes, a deliberate well being subscription service designed to assist individuals with Kind 2 diabetes and prediabetes via personalised life-style teaching, at this time introduced that its CEO Dr. Faz Chowdhury will likely be presenting on the LD 500 investor convention on Thursday, September 3, 2020 at 10:20 a.m. ET.
Within the presentation, Dr. Chowdhury will present perception into the Firm’s progress on product rollouts within the USA, Germany and UK, in addition to using its CGM and lactate monitoring options for monitoring of illness development in COVID-19 sufferers.
Register right here: https://ld500.ldmicro.com/
“We now have been ready for this second all yr lengthy. As a consequence of COVID, it has been practically not possible for bodily conferences to even happen. I wish to present the world you can nonetheless be taught, have a good time, and see among the most unusual firms within the capital markets at this time. All with out having to step foot outdoors. For the primary time, LD Micro is accessible to everybody, and we’re honored to welcome you to one of the trusted platforms within the house.” said Chris Lahiji, Founding father of LD.
The LD 500 will happen on September 1st via the 4th.
View Nemaura Medical’s profile right here:
About Nemaura Medical, Inc.:
Nemaura Medical Inc. (NMRD) is a medical know-how firm creating micro-systems-based wearable diagnostic gadgets and at present commercializing sugarBEAT®, and proBEAT™. sugarBEAT®, a CE mark accepted Class IIb medical system, is a non-invasive and versatile steady glucose monitor (CGM) offering actionable insights derived from actual time glucose measurements and day by day glucose development knowledge, which can assist individuals with diabetes and pre-diabetes to higher handle, reverse and stop the onset of diabetes. Nemaura has additionally submitted a PMA software for sugarBEAT® to the US FDA. proBEAT™ contains a non-invasive glucose monitor and a digital healthcare subscription service and is because of be launched within the US as a normal wellness product.